Evaluation of the Erysipelothrix rhusiopathiae antigenic component in bivalent porcine parvovirus and E. rhusiopathiae vaccines by humoral immune responses in pigs

Home Knowledge Evaluation of the Erysipelothrix rhusiopathiae antigenic component in bivalent porcine parvovirus and E. rhusiopathiae vaccines by humoral immune responses in pigs

Evaluation of the Erysipelothrix rhusiopathiae antigenic component in bivalent porcine parvovirus and E. rhusiopathiae vaccines by humoral immune responses in pigs

This study aimed to compare the humoral immune responses elicited in naïve pigs by three different inactivated bivalent porcine parvovirus (PPV) and Erysipelothrix rhusiopathiae vaccines against E. rhusiopathiae.

About this article

Appeared in

ESPHM Congress, 2014

Authors

Fontseca, M.; Muñoz, J.; Roca, M.; Camprodon, A.; March, R: Sitjà, M.

Summary

The humoral immune response against E. rhusiopathiae in the group of animals vaccinated with the new vaccine is faster, higher and lasts longer than the humoral immune response developed by the other vaccines.

Related services

Related products

Share this on